These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 19409809

  • 1. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH.
    Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
    [Abstract] [Full Text] [Related]

  • 2. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG, Sadik NA.
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [Abstract] [Full Text] [Related]

  • 4. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B, Dispan R, Radinahamed P, Kitiyakara C.
    BMC Nephrol; 2018 Sep 21; 19(1):246. PubMed ID: 30241508
    [Abstract] [Full Text] [Related]

  • 5. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.
    Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G.
    Diabetes Care; 2003 Sep 21; 26(9):2632-6. PubMed ID: 12941731
    [Abstract] [Full Text] [Related]

  • 6. Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
    Ibrahim S, Rashed L.
    Saudi J Kidney Dis Transpl; 2008 Nov 21; 19(6):911-7. PubMed ID: 18974575
    [Abstract] [Full Text] [Related]

  • 7. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Knowler WC, Rovin BH, Wu H, Klein JB, Mifflin TE, Feldman HI, Vasan RS, Kimmel PL, Kusek JW, Mauer M, CKD Biomarkers Consortium and the RASS Investigators.
    Nephrol Dial Transplant; 2015 Apr 21; 30(4):599-606. PubMed ID: 25648911
    [Abstract] [Full Text] [Related]

  • 8. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
    Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    Ren Fail; 2003 May 21; 25(3):439-44. PubMed ID: 12803507
    [Abstract] [Full Text] [Related]

  • 9. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N, Skupien J, Smiles AM, Yamanouchi M, Niewczas MA, Galecki AT, Duffin KL, Breyer MD, Pullen N, Bonventre JV, Krolewski AS.
    Kidney Int; 2018 May 21; 93(5):1198-1206. PubMed ID: 29398132
    [Abstract] [Full Text] [Related]

  • 10. [Urinary excretion of proinflammatory cytokines and transforming growth factor beta at early stages of diabetic nephropathy].
    Bondar' IA, Klimontov VV, Nadeev AP.
    Ter Arkh; 2008 May 21; 80(1):52-6. PubMed ID: 18326229
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY, Chen FQ.
    Diabetes Res Clin Pract; 2009 Feb 21; 83(2):215-9. PubMed ID: 19097668
    [Abstract] [Full Text] [Related]

  • 12. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
    Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    J Diabetes Complications; 2003 Feb 21; 17(1):11-5. PubMed ID: 12505750
    [Abstract] [Full Text] [Related]

  • 13. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD, Zheng M, Zhao LL, Qian Y, Yao XM, Ren A, Li SM, Jing CY.
    Eur J Clin Invest; 2009 Nov 21; 39(11):980-5. PubMed ID: 19663918
    [Abstract] [Full Text] [Related]

  • 14. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
    Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K.
    Kidney Int; 2000 Aug 21; 58(2):684-90. PubMed ID: 10916091
    [Abstract] [Full Text] [Related]

  • 15. Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
    Titan SM, Vieira JM, Dominguez WV, Moreira SR, Pereira AB, Barros RT, Zatz R.
    J Diabetes Complications; 2012 Aug 21; 26(6):546-53. PubMed ID: 22981148
    [Abstract] [Full Text] [Related]

  • 16. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, Sasaki H, Narita T, Ito S, Kakei M.
    Endocr J; 2006 Dec 21; 53(6):745-52. PubMed ID: 16966829
    [Abstract] [Full Text] [Related]

  • 17. Nuclear NF-κB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.
    Yi B, Hu X, Zhang H, Huang J, Liu J, Hu J, Li W, Huang L.
    PLoS One; 2014 Dec 21; 9(6):e99633. PubMed ID: 24936866
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
    Bouvet BR, Paparella CV, Arriaga SM, Monje AL, Amarilla AM, Almará AM.
    Arq Bras Endocrinol Metabol; 2014 Nov 21; 58(8):798-801. PubMed ID: 25465599
    [Abstract] [Full Text] [Related]

  • 19. Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report.
    Riser BL, Cortes P, DeNichilo M, Deshmukh PV, Chahal PS, Mohammed AK, Yee J, Kahkonen D.
    Kidney Int; 2003 Aug 21; 64(2):451-8. PubMed ID: 12846740
    [Abstract] [Full Text] [Related]

  • 20. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R, Brachemi S, Pichette V, Cartier P, Laforest-Renald A, MacRae T, Madore F, Troyanov S.
    J Nephrol; 2011 Aug 21; 24(1):60-7. PubMed ID: 20437404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.